申请人:WAN Zehong
                            
                            
                                公开号:US20130178488A1
                            
                            
                                公开(公告)日:2013-07-11
                            
                            The present invention relates to novel compounds that inhibit Lp-PLA
2
activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA
2
, for example atherosclerosis, Alzheimer's disease, and/or diabetic macular edema.